Product Details
Ipamorelin
Overview: Ipamorelin is a synthetic pentapeptide known for its specificity in stimulating growth hormone release without significantly affecting other hormones such as ACTH and cortisol.
Product Specifications:
- Purity: ≥99% (HPLC verified)
- Formulation: Lyophilized powder
- Molecular Formula: C38H49N9O5
- Molecular Weight: 711.868 g/mol
- CAS Number: 170851-70-4
- PubChem CID: 9831659
Source: PubChem
Product Features:
- Specific activation of growth hormone secretagogue receptor
- Minimal effect on ACTH, cortisol, prolactin, and thyroid-stimulating hormone
- Potential therapeutic and research applications due to high receptor selectivity
Research Applications:
- Growth Hormone Deficiencies: Studies indicate its potential in stimulating pituitary growth hormone release.
- Muscle Wasting: May counteract muscle wasting associated with glucocorticoid use.
- Bone Health: Shown to potentially reverse bone loss and improve bone mineral density.
- Diabetes: May play a role in diabetes management through its effects on insulin and blood sugar levels.
- Post-Operative Ileus: Studied for its potential to reduce post-operative ileus, improving gastrointestinal recovery.
Conclusion: Ipamorelin's selective growth hormone-releasing effects, combined with its minimal impact on other hormones, make it a focus of research into growth deficiencies, muscle wasting, bone health, metabolic syndrome, and gastrointestinal recovery.
Important Notice: This product is designated for research purposes only and is not approved for human consumption. It should be handled by qualified professionals, strictly for in vitro research and educational purposes.
COA Batch 1708-0124-2 (2mg)
Batch 1708-0124-2
COA Batch 1708-0624-5HHT (5mg)
Batch 1708-0624-5HHT
